The Albanese Government has released its 2023-24 Mid-Year Economic Fiscal Outlook, which includes $3.5 billion since the May Budget for new medicines on the PBS, but also an expected decline in spending on the program that must be qualified because the estimate does not include the impact of future new listings.
Update reveals significant spending on new listings since the May Budget
December 13, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
The unseen price of survival for women facing early breast cancer in Australia
March 27, 2026 - - Latest News -
This is the not so quiet demand and doctrine of rationed health care
March 27, 2026 - - Latest News -
If these can be presented as positives, then we really have become accustomed to terrible
March 26, 2026 - - Latest News -
Liberty expands into Asia Pacific life sciences insurance with new tailored offering
March 25, 2026 - - Australian Biotech -
Budget delivers progress, but hundreds of thousands still waiting for access
March 25, 2026 - - Latest News -
To what extent does the system even see itself as bound by external review?
March 25, 2026 - - Latest News -
PBAC agenda reflects increasing number of companies seeking revised recommendations
March 25, 2026 - - Latest News
